Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research ...

New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE--BUSINESS WIRE--Parse Biosciences, the leading provider ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Global Bioanalytical Services Market is anticipated to witness a healthy double-digit growth rate by 2027. The rising ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for ...

Aquarius (Jan. 20∼Feb. 18) Today, the flow is good. Things will go smoothly in the desired direction. In particular, ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider ...

胶质母细胞瘤（Glioblastoma, ...

The Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation have awarded Dr. Owen Witte(Link is external) (Link opens in new window) with the twelfth ...